|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"w c"
Showing items 31-40 of 121 (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024 |
Fluorescent sensing copolymers: Synthesis, nanofiber fabrication and application in picric acid sensors
|
Lin;H, -J.;Tseng;P, -H.;Wu;W, -C. |
| 國立成功大學 |
2024 |
Downregulation of SIRT1 and GADD45G genes and left atrial fibrosis induced by right ventricular-dependent pacing in a complete atrioventricular block pig model
|
Lee;W, -C.;Lin;Y, -S.;Chen;M, -J.;Ho;W, -C.;Chen;H, -C.;Chang;T, -H.;Liu;P, -Y.;Chen;M, -C. |
| 國立成功大學 |
2024 |
Geographic differences in susceptibility profiles of potential non-class B carbapenemase-producing Enterobacterales isolates against ceftazidime-avibactam, meropenem-vaborbactam, colistin, amikacin, gentamicin, and tigecycline: Data from the Antimicrobial
|
Jean;S, -S.;Ko;W, -C.;Liu;I, -M.;Shieh;P, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–2021
|
Wang;J, -L.;Lai;C, -C.;Tsai;Y, -W.;Ko;W, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–21
|
Wang;J, -L.;Lai;C, -C.;Tsai;Y, -W.;Hsueh;C, -C.;Ko;W, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014–2021, and re-estimations of susceptibility breakpoin
|
Hsueh;S, -C.;Huang;Y, -T.;Ko;W, -C.;Liu;I, -M.;Shieh;P, -C.;Jean;S, -S. |
| 國立成功大學 |
2024 |
Minimum inhibitory concentrations of antifungals against invasive isolates of Cryptococcus species worldwide: Global antifungal antimicrobial testing leadership and surveillance program, 2010–2020
|
Jean;S, -S.;Liu;C, -Y.;Huang;Y, -T.;Ko;W, -C.;Ho;M, -W.;Liu;I, -M.;Shieh;P, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
Decrease of KATP channel expression through D3 receptor-mediated GSK3β signaling alleviates levodopa-induced dyskinesia (LID) in Parkinson's disease mouse model
|
Kuo;Y, -Y.;Pen;S, -Y.;Cheng;C, -H.;Ho;W, -C.;Chen;C, -Y.;Wu;W, -C.;Chou;H, -H.;Chen;J, -Y.;Lin;C, -H.;Lin;J, -F.;Yang;S, -B.;Chen;P, -C. |
| 國立成功大學 |
2024 |
Association of sodium–glucose cotransporter-2 inhibitors and the risk of retinal vascular occlusion: A real-world retrospective cohort study in Taiwan
|
Lin;T, -Y.;Kang;E, Y.-C.;Shao;S, -C.;Lai;E, C.-C.;Wang;N, -K.;Garg;S, J.;Chen;K, -J.;Kang;J, -H.;Wu;W, -C.;Lai;C, -C.;Hwang;Y, -S. |
| 國立成功大學 |
2024 |
Efficacy of short- versus prolonged-courses of antimicrobial therapy for carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A propensity score-matched cohort study
|
You;T, -Y.;Lo;C, -L.;Tsai;W, -C.;Jan;H, -E.;Ko;W, -C.;Lee;N, -Y. |
Showing items 31-40 of 121 (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
